Literature DB >> 14622960

An interference-free fluorescent assay of telomerase for the high-throughput analysis of inhibitors.

Rawle Francis1, Simon H Friedman.   

Abstract

We have developed a telomerase assay that can quickly and accurately rank the ability of molecules to inhibit telomerase activity. It is based on the method of Orlando and co-workers which utilizes PicoGreen to detect dsDNA formed during the polymerase chain reaction (PCR) amplification of telomerase products. PCR cycles were optimized to give as linear a signal as possible relative to telomerase products; 96-well streptavidin-coated PCR plates were used to isolate the preamplification telomerase products and to wash inhibitors away before the amplification step. The inhibitor removal step is critical to prevent false positives potentially caused by inhibition of Taq polymerase during amplification. Use of the streptavidin-coated PCR plate allows this step to be done much more rapidly than use of the liquid/liquid extraction adopted by others. We have demonstrated that this assay can correctly order the ability of four inhibitors to inhibit telomerase and reproduce within a factor of two the absolute IC(50) values determined by the more time-consuming direct assay. We have shown that the difference in IC(50) values determined in this assay versus the direct assay can be corrected for by using the standard curve appropriately. Using this method 96 compounds can be assessed in 3-5h.

Mesh:

Substances:

Year:  2003        PMID: 14622960     DOI: 10.1016/j.ab.2003.08.021

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  3 in total

1.  Targeting human telomerase for cancer therapeutics.

Authors:  Lionel Guittat; Patrizia Alberti; Dennis Gomez; Anne De Cian; Gaëlle Pennarun; Thibault Lemarteleur; Chafke Belmokhtar; Rajaa Paterski; Hamid Morjani; Chantal Trentesaux; Eliane Mandine; François Boussin; Patrick Mailliet; Laurent Lacroix; Jean-François Riou; Jean-Louis Mergny
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

2.  Drug binding to DNA x RNA hybrid structures.

Authors:  Richard T Wheelhouse; Jonathan B Chaires
Journal:  Methods Mol Biol       Date:  2010

3.  Inhibition of therapeutically important polymerases with high affinity bis-intercalators.

Authors:  Nitin Jain; Subhashree Francis; Simon H Friedman
Journal:  Bioorg Med Chem Lett       Date:  2012-05-23       Impact factor: 2.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.